Investigating heart disease risk factors in diverse communities
Official title: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - COORDINATING CENTER - TASK AREA B.2 AND B.3
Funded at Univ of North Carolina Chapel Hill · NIH-11292917 · Data updated 2026-11-12
This study is looking at what causes atherosclerosis, a condition that can lead to heart disease, by gathering health information from middle-aged adults in four U.S. communities to help us better understand how to prevent heart problems in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | November 15, 2024 |
| Project end | September 30, 2025 |
| Funding year | 2025 |
| Award (this year) | $1,201,915 |
| NIH project number | 75N92022D00001-0-759202500001-1 |
| Project ID | NIH-11292917 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include middle-aged adults, particularly those aged 45-64 years, from diverse racial backgrounds, especially African American individuals.
✕Less likely to help
Patients who are younger than 45 years or do not have a history of cardiovascular issues may not benefit from this research.
What this research studies
This research focuses on understanding the risk factors and progression of atherosclerosis, a condition that can lead to heart disease, by analyzing data from a large cohort of participants across four U.S. communities. The study involves ongoing clinical exams and surveillance of heart-related events, allowing researchers to track changes in health over time. Participants, primarily middle-aged white and African American adults, will contribute to identifying genetic and environmental influences on heart health. The findings aim to enhance knowledge about heart disease and improve prevention strategies.
Why it matters
Potential benefit: If successful, this research could lead to better prevention and treatment strategies for heart disease, particularly in diverse populations.
How similar studies have gone: Previous studies on atherosclerosis and heart disease risk factors have shown significant success, indicating that this approach is grounded in established research.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Couper, David — Univ of North Carolina Chapel Hill
- Study coordinator: Couper, David
Related research
Other NIH-funded projects on the same topics.
-
Coronary disease and immune activation in people with HIV and tuberculosis coinfection
This research looks at how having HIV and latent tuberculosis together might raise the risk of heart disease, and what immune changes are involved.
-
PFAS may speed up artery disease by changing bile acids
Aims to see if PFAS chemicals make cholesterol rise and arteries more likely to harden, using a human-similar mouse model to understand how this could affect people.
-
IgE antibodies to alpha-gal and heart disease in mice and people
A study to understand how specific IgE antibodies against alpha-gal might influence the development and severity of atherosclerosis in humans and mouse models.
-
Fibroblast Growth Factor 1 to Reduce High Lipids and Plaque in Adults with Diabetes
A new approach uses a modified FGF1 protein to lower bad cholesterol and prevent artery plaque buildup in adults with Type 2 diabetes, aiming for safer and more effective treatment.
-
Atherosclerosis in cocaine addiction: imaging risk with PET/MR
This project uses PET/MR imaging to look for early artery disease in people with cocaine use disorder to help prevent strokes or other brain injuries.
-
How low blood flow after brain artery narrowing affects the vessel lining
This work looks at whether areas of low blood flow downstream of narrowed brain arteries cause vessel lining damage and raise the chance of another stroke, for people with intracranial artery narrowing.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.